Vivus obesity drug has safety risks: FDA staff
(Reuters)
[unable to retrieve full-text content]Reuters - Vivus Inc's obesity drug Qnexa helped people lose weight but may cause long-term health problems in overweight and obese patients, U.S. drugs reviewers said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.